Clinical Trials Directory

Trials / Sponsors / Lumosa Therapeutics Co., Ltd.

Lumosa Therapeutics Co., Ltd.

Industry · 8 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
CompletedA Study to Evaluate the Safety and Efficacy of Multiple Doses of LT3001 Drug Product in AIS Subjects
Acute Ischemic Stroke
Phase 22022-08-17
RecruitingA Study to Evaluate the Safety and Efficacy of LT3001 Drug Product in Subjects AIS Undergoing EVT
Acute Ischemic Stroke
Phase 22022-08-11
CompletedA Study to Evaluate Safety and PK of Multiple Doses of LT3001 Drug Product and Drug-drug Interaction in Health
Acute Ischemic Stroke
Phase 12021-03-21
TerminatedStudy to Investigate the Safety of LT5001 Drug Product for Uremic Pruritus in Hemodialysis Patients
Uremic Pruritus
Phase 1 / Phase 22020-05-14
CompletedA Bioavailability Study of NALDEBAIN ER Injection and Nalbuphine Injection in Healthy Volunteers.
Health
Phase 12020-01-31
CompletedA Study to Evaluate the Safety and Potential Efficacy of LT3001 Drug Product in Subjects With AIS
Acute Ischemic Stroke
Phase 22020-01-27
CompletedA Bioavailability Study of Sebacoyl Dinalbuphine Ester IM Injection in Healthy Volunteers
Pain, Analgesia Disorder
Phase 12015-01-01
CompletedA Study of Intramuscular Sebacoyl Dinalbuphine Ester for Post-Hemorrhoidectomy Pain Management
Analgesia Disorder, Pain
Phase 2 / Phase 32012-12-01